Table 6 SEs experienced by participants after taking DTG-based ART (N = 461)
Variable | ART Naive | ART Experienced | ||
|---|---|---|---|---|
Frequency | Proportion of total (%) | Frequency | Proportion of total (%) | |
Neuropsychiatric (n = 98) |  |  |  |  |
Abnormal dreams Insomnia Depression Confusion | 2 4 0 0 | 0.4 0.9 0 0 | 27 40 6 19 | 5.9 8.7 1.3 4.2 |
Central Nervous System (n = 105) |  |  |  |  |
Dizziness Headaches Memory loss Neuralgia | 1 2 0 0 | 0.2 0.4 0 0 | 40 56 1 5 | 8.8 12.4 0.2 1.1 |
Gastrointestinal (n = 80) |  |  |  |  |
Nausea Vomiting Abdominal pain Constipation Diarrhoea Heartburn | 1 0 2 0 1 0 | 0.2 0 0.4 0 0.2 0 | 28 4 36 3 2 3 | 6.2 0.9 7.9 0.7 0.4 0.7 |
Dermatological (n = 70) |  |  |  |  |
Rash Dry skin | 8 0 | 1.8 0 | 59 3 | 13.0 0.7 |
Musculoskeletal (n = 72) |  |  |  |  |
Malaise/tiredness Arthralgia Cramps | 5 0 1 | 1.1 0 0.2 | 56 7 3 | 12.4 1.5 0.7 |
Miscellaneous (n = 28) |  |  |  |  |
Enlargement of breasts Cough Edema Loss of appetite Facial swelling Night sweats Weight gain Weight loss | 0 0 0 1 0 0 1 0 | 0 0 0 0.2 0 0 0.2 0 | 12 2 1 3 3 1 3 1 | 2.6 0.4 0.2 0.7 0.7 0.2 0.7 0.2 |